United States · FDA National Drug Code directory
TRYVIO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46014-8012_3089b47c-2917-d828-e063-6394a90a6d2a
- Product NDC
- 46014-8012
- Form
- CAPSULE
- Composition / generic term
- TRYVIO
- Labeler
- Excella GmbH & Co. KG
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20241001
- Source listing expiry
- 20261231
Source-listed ingredients
- APROCITENTAN — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (46014-8012-3) · 46014-8012-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →